Welcome to the New Nuclear Medicine Technologist Section, providing you access to everything you need on the SNMMI website in one place.
The nuclear medicine and molecular imaging technologists are highly specialized healthcare professionals who works closely with the nuclear medicine physician. Some of the technologist’s primary responsibilities are to: Prepare and administer radioactive chemical compounds, known as radiopharmaceuticals and to administer adjunctive medications in order to perform patient imaging procedures using sophisticated instrumentation; Process data and enhance digital images using advanced computer technology; Provide images, data analysis, and patient information to the physician for diagnostic interpretation; and Evaluate new procedures for appropriateness in specific clinical settings and patient populations.
The Society of Nuclear Medicine and Molecular Imaging Technologist Section as part of the SNMMI, is constantly striving to make a difference in the way nuclear medicine and molecular imaging technologists receive academic and continuing education as well as information concerning new procedures, technologies and equipment. Research has been a vital part of SNMMI-TS activities for many years, as has monitoring federal regulation and influencing decisions that affect the practice of nuclear medicine.
In addition to providing discussion forums and publishing journals, newsletters and books, SNMMI-TS also sponsors international meetings and workshops designed to increase the competencies of nuclear medicine practitioners and to promote new scientific advances. The activities of the SNMMI-TS National Council of Representatives, volunteer committee members, and staff focus on improving the quality of care for the patients served by technologists around the world.
Learn more about Nuclear Medicine and Molecular Imaging Technologists.
SNMMI educational programs are designed to meet the professional development needs of technologists in the field of nuclear medicine and molecular imaging, as well as providing them with continuing education credit opportunities. SNMMI is an ARRT-recognized conitinuing education mechanism (RCEEMs) provider through the Society's Verification Of Involvement in Continuing Education (VOICE) program.
The PET Online Review Workshop is designed to help prepare technologists for the NMTCB's PET Exam. Following the NMTCB's content outline, the workshop offers a comprehensive review of both PET and PET/CT.
The NCT (Nuclear Cardiology Technologist) Online Review Workshop is designed to prepare technologists for the NMTCB's NCT Exam. The course reviews the NMTCB's nuclear cardiology examination content specifications.
Introducing a new member-benefit. Stay on top of the latest trends and advancements in the profession with quarterly technologist-focused webinars—free for SNMMI-TS members.
The profession of nuclear medicine and molecular imaging has evolved over the past several years, and continues to evolve to include imaging and therapy beyond the sole use of radioactive materials. Fusion imaging, combining traditional nuclear medicine with other imaging technologies like CT and MRI and their related contrast agents, as well as new and exciting areas like fluorescence imaging are examples of this. ‘Molecular imaging and therapy’ is a phrase which has been developed in recognition of this expansion. As such, the SNMMI-TS has embraced this evolution with a vision of being the recognized leader in this exciting and ever-growing arena.
The SNMMI-TS offers several professional advancement opportunities, including the SNMMI-TS Leadership Academy and Porfessional Development Awards and Scholarships. Learn more.
In addition, there are several advanced degree programs and certifications available to the nuclear medicine technologist. Specific areas include; the Nuclear Medicine Advanced Associate (masters degree and certification), PET Certification Exam, CT Certification Exam and NCT Certification Exam. Learn more about these and other opportunities.
The spectrum of responsibilities for a nuclear medicine technologist varies widely across the United States. Practice components presented in this document provide a basis for establishing the areas of knowledge and performance for the nuclear medicine technologist. The nuclear medicine technologist must be in compliance with all federal, state, and institutional guidelines, including proper documentation of initial and continued competency in those practices and activities.
Continuing education is a necessary component in maintaining the skills required to perform all duties and tasks of the nuclear medicine technologist in this ever-evolving field.
The Nuclear Medicine Technologist Scope of Practice and Performance Standards document is intended to set forth the standards in important areas of the nuclear medicine technologist’s responsibilities. It may not cover all areas which may present themselves in actual practice. These standards do not supersede the judgment of the individual nuclear medicine technologist and other healthcare professionals serving the patient in light of all of the facts of the individual case. THE SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING AND THE SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING TECHNOLOGIST SECTION DISCLAIM ALL LIABILITY ARISING FROM USE OF THESE DOCUMENTS.
The SNMMI-TS has a robust grants and awards program sponsored in part by the Education and Research Foundation (ERF). The numerous grants and awards offered spam from financial assistance for tuition for advanced degree programs, travel awards to attend the annual meeting, best abstract awards for abstracts presented during the annual meeting, clinical advancement awards and the leadership academy.
Currently accepting applications:
Click here to learn more about all of the available SNMMI-TS awards.
Visit SNMMI's Career Center.
In order to alleviate the current shortage of Xofigo® (radium Ra 223 dichloride) Injection (Xofigo®), Bayer HealthCare Pharmaceuticals (Bayer) is currently coordinating with the US Food and Drug Administration (FDA) to increase the availability of the drug. Bayer is currently experiencing a drug shortage for Xofigo® (radium Ra 223 dichloride) due to a production issue.
SNMMI and the North American Neuroendocrine Tumor Society (NANETS) held their first joint symposium to provide an in-depth review of the clinical utility of the nuclear medicine technologies for NETs.
Combining a PET scanner with a new chemical tracer that selectively tags specific types of bacteria, Johns Hopkins researchers - working with mice report - have devised a way to detect and monitor in real time infections with a class of dangerous Gram-negative bacteria.
(MI: Making a Difference)
Scientists say they have identified the underlying reason why some people are prone to the winter blues, or seasonal affective disorder (SAD).
(MI: Making a Difference)
Renew Your Membership!
Your Membership Expires:
September 30, 2014
Please take a moment to renew your SNMMI-TS membership for 2014-15 and maintain your commitment to excellence as you help guide the future of healthcare and personalized medicine.
*Please Note: Your membership year runs from October 1 to September 30, regardless of your join date.